3 6 Ke·2026-01-23 03:16Core Viewpoint - The article discusses the rising trend of peptide injections among Silicon Valley elites, highlighting the unregulated and experimental nature of this practice, which is largely driven by the desire for enhanced physical performance and anti-aging effects. Group 1: Peptide Injection Trend - Silicon Valley elites are purchasing peptide compounds from Chinese factories and self-administering them, often in social settings, reflecting a culture of experimentation and a desire for improved health and performance [2][3][5]. - The most popular peptide, Semaglutide, is known for its weight loss effects, attracting many users due to its affordability compared to FDA-approved products [6][8]. - Reports indicate that the import of hormones and peptide compounds from China to the U.S. reached approximately $328 million in the first three quarters of 2025, nearly double the amount from the same period in 2024, indicating strong market demand despite safety concerns [6][8]. Group 2: Market Dynamics in China - In contrast to the injection trend in the U.S., the Chinese market primarily focuses on topical peptide products, with skincare products accounting for 89.68% of the peptide market share [9][10]. - The Chinese peptide market is projected to grow from 2.17 billion yuan in 2024 to 4.67 billion yuan by 2029, indicating a significant growth phase for the industry [17]. - Major Chinese brands like Han Shu have successfully integrated peptides into their skincare lines, achieving a market share of 34.59% in the peptide skincare segment [11][13]. Group 3: Manufacturing and Innovation - China has established itself as the global manufacturing hub for peptide products, benefiting from technological advancements and a complete industrial chain [18][20]. - Companies like Hanyu Pharmaceutical and Jiangsu Nuotai Biotech are leading the way in peptide production, with Hanyu achieving a production capacity of over ten tons annually [22][20]. - The total output value of China's peptide industry is expected to reach 247.6 billion yuan by 2030, with a projected annual growth rate of 18.4% [22].